Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

Please provide your email address to receive an email when new articles are posted on . Racial and ethnic disparities in buprenorphine treatment duration increased from 2006 to 2020, but particularly ...

Despite a slowdown in new waivers to prescribe buprenorphine during COVID-19, treatment capacity nonetheless grew at a stable rate, a new Health Affairs study has found. This was due to already ...

Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...

All of our services are outpatient - office based treatment. Our patients are initially seen to determine if they are suffering from Opioid Use Disorder and if they are appropriate for Buprenorphine ...

During the COVID-19 pandemic, there was slower growth in the number of new waivers authorizing clinicians to provide buprenorphine treatment for opioid use disorder. However, treatment capacity grew ...

India, March 19 -- Weekly buprenorphine injections demonstrate a superior safety profile compared to daily oral dosing and serve as a highly effective treatment for Opioid Use Disorder (OUD) in ...

Please provide your email address to receive an email when new articles are posted on . Nonadherence to treatment with buprenorphine is associated with an increased risk of opioid overdose as well as ...

Buprenorphine treatment for pregnant patients with opioid use disorder (OUD) was linked with fewer neonatal risks compared with methadone therapy, but had similar maternal outcomes, an analysis of ...

A new study, led by a Rutgers researcher, found that buprenorphine, rather than methadone, may be safer for infants born to mothers getting treatment for opioid use disorder. This July 23, 2018 file ...

Suboxone (buprenorphine/naloxone) is a brand-name prescription drug used to treat dependence on opioid drugs. This is also known as opioid use disorder. As with other medications, Suboxone can ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...